BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35333684)

  • 1. Nucleotide pyrophosphatase/phosphodiesterases (NPPs) including NPP1 and NPP2/ ATX as important drug targets: A patent review (2015-2020).
    Bano S; Al-Rashida M; Alharthy RD; Khan IA; Iqbal J
    Expert Opin Ther Pat; 2022 Jul; 32(7):743-751. PubMed ID: 35333684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An updated patent review of autotaxin inhibitors (2017-present).
    Tan Z; Lei H; Guo M; Chen Y; Zhai X
    Expert Opin Ther Pat; 2021 May; 31(5):421-434. PubMed ID: 33342311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Glycomic and Microscopic Subcellular Localization Analyses of NPP1, 2 and 6 Strongly Indicate that trans-Golgi Compartments Participate in the Golgi to Plastid Traffic of Nucleotide Pyrophosphatase/Phosphodiesterases in Rice.
    Kaneko K; Takamatsu T; Inomata T; Oikawa K; Itoh K; Hirose K; Amano M; Nishimura S; Toyooka K; Matsuoka K; Pozueta-Romero J; Mitsui T
    Plant Cell Physiol; 2016 Aug; 57(8):1610-28. PubMed ID: 27335351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity and expression of ecto-nucleotide pyrophosphate/phosphodiesterases in a hepatic stellate cell line.
    Andrade CM; Wink MR; Margis R; Borojevic R; Battastini AM; Guma FC
    Mol Cell Biochem; 2009 May; 325(1-2):179-85. PubMed ID: 19194664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as inhibitors of nucleotide pyrophosphatases/phosphodiesterases and anticancer agents.
    Anbar HS; El-Gamal R; Ullah S; Zaraei SO; Al-Rashida M; Zaib S; Pelletier J; Sévigny J; Iqbal J; El-Gamal MI
    Bioorg Chem; 2020 Nov; 104():104305. PubMed ID: 33017718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors.
    al-Rashida M; Iqbal J
    Med Res Rev; 2014 Jul; 34(4):703-43. PubMed ID: 24115166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents.
    Ullah S; El-Gamal MI; El-Gamal R; Pelletier J; Sévigny J; Shehata MK; Anbar HS; Iqbal J
    Eur J Med Chem; 2021 May; 217():113339. PubMed ID: 33744686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate-specifying determinants of the nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP2.
    Cimpean A; Stefan C; Gijsbers R; Stalmans W; Bollen M
    Biochem J; 2004 Jul; 381(Pt 1):71-7. PubMed ID: 15096095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of biphenyl oxazole derivatives via Suzuki coupling and biological evaluations as nucleotide pyrophosphatase/phosphodiesterase-1 and -3 inhibitors.
    Ahmad H; Ullah S; Rahman F; Saeed A; Pelletier J; Sévigny J; Hassan A; Iqbal J
    Eur J Med Chem; 2020 Dec; 208():112759. PubMed ID: 32883636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide pyrophosphatases/phosphodiesterases on the move.
    Bollen M; Gijsbers R; Ceulemans H; Stalmans W; Stefan C
    Crit Rev Biochem Mol Biol; 2000; 35(6):393-432. PubMed ID: 11202013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitors.
    Eliahu S; Lecka J; Reiser G; Haas M; Bigonnesse F; Lévesque SA; Pelletier J; Sévigny J; Fischer B
    J Med Chem; 2010 Dec; 53(24):8485-97. PubMed ID: 21090681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide pyrophosphatase/phosphodiesterase 1 exerts a negative effect on starch accumulation and growth in rice seedlings under high temperature and CO2 concentration conditions.
    Kaneko K; Inomata T; Masui T; Koshu T; Umezawa Y; Itoh K; Pozueta-Romero J; Mitsui T
    Plant Cell Physiol; 2014 Feb; 55(2):320-32. PubMed ID: 24092883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazolo[3,2-a]benzimidazol-3(2H)-one derivatives: Structure-activity relationships of selective nucleotide pyrophosphatase/phosphodiesterase1 (NPP1) inhibitors.
    Lee SY; Perotti A; De Jonghe S; Herdewijn P; Hanck T; Müller CE
    Bioorg Med Chem; 2016 Jul; 24(14):3157-65. PubMed ID: 27265686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autotaxin inhibitors: a patent review (2012-2016).
    Nikolaou A; Kokotou MG; Limnios D; Psarra A; Kokotos G
    Expert Opin Ther Pat; 2017 Jul; 27(7):815-829. PubMed ID: 28447479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression mapping of ectonucleotide pyrophosphatase/phosphodiesterase 1-3 (E-NPP1-3) in different brain structures during rat development.
    Cognato Gde P; Czepielewski RS; Sarkis JJ; Bogo MR; Bonan CD
    Int J Dev Neurosci; 2008 Oct; 26(6):593-8. PubMed ID: 18565716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrolysis of diadenosine polyphosphates by nucleotide pyrophosphatases/phosphodiesterases.
    Vollmayer P; Clair T; Goding JW; Sano K; Servos J; Zimmermann H
    Eur J Biochem; 2003 Jul; 270(14):2971-8. PubMed ID: 12846830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of NPP1, an ectonucleotide pyrophosphatase/phosphodiesterase involved in tissue calcification.
    Jansen S; Perrakis A; Ulens C; Winkler C; Andries M; Joosten RP; Van Acker M; Luyten FP; Moolenaar WH; Bollen M
    Structure; 2012 Nov; 20(11):1948-59. PubMed ID: 23041369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyoxometalates--potent and selective ecto-nucleotidase inhibitors.
    Lee SY; Fiene A; Li W; Hanck T; Brylev KA; Fedorov VE; Lecka J; Haider A; Pietzsch HJ; Zimmermann H; Sévigny J; Kortz U; Stephan H; Müller CE
    Biochem Pharmacol; 2015 Jan; 93(2):171-81. PubMed ID: 25449596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship study of NPP1 inhibitors based on uracil-N1-(methoxy)ethyl-β-phosphate scaffold.
    Nassir M; Pelletier J; Arad U; Arguin G; Khazanov N; Gendron FP; Sévigny J; Senderowitz H; Fischer B
    Eur J Med Chem; 2019 Dec; 184():111754. PubMed ID: 31610377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and catalytic similarities between nucleotide pyrophosphatases/phosphodiesterases and alkaline phosphatases.
    Gijsbers R; Ceulemans H; Stalmans W; Bollen M
    J Biol Chem; 2001 Jan; 276(2):1361-8. PubMed ID: 11027689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.